Scientists at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs.
The findings, published online in the Journal of Proteome Research, are significant because current newborn screening methods are not accurate enough to identify the disorder in the population, which can manifest itself in many different ways, requiring additional testing and causing further stress for anxious parents.
“The earlier CF is detected, the earlier it can be managed and treated, which means better health outcomes for affected infants, including their future growth and development,” says Philip Britz-McKibbin, lead author of the study and a professor in McMaster’s Department of Chemistry & Chemical Biology, who conducted the research with graduate student Alicia DiBattista, now a postdoctoral fellow at Newborn Screening Ontario (NSO).
A tiny amount of blood is drawn from the heel of all babies as part of universal newborn screening programs that test for many rare yet treatable diseases since babies usually have no signs of disease at birth, including CF.
In the case of CF, infants are screened for a pancreatic enzyme and then a panel of disease-causing genetic mutations associated with CF. However, further testing to confirm or rule out the disease finds that most babies who screen-positive do not actually have the disease. These babies are later found to be “healthy carriers” or their results are deemed to be “false positives”.
With this in mind, researchers set out to determine whether they could discover chemical signatures in a dried blood spot that could better distinguish infants who have CF from those who do not.
Using less than a single drop of blood stored at NSO at CHEO, a pediatric health and research centre in Ottawa, researchers analyzed and compared samples from infants confirmed to have CF with the samples of both healthy and screen positive infants. They found several new compounds as well as simple amino acids directly related to affected infants with CF who otherwise have no symptoms and normal birth weight.
“These biomarkers provide new insights into the disease process early in life before symptoms are fully apparent,” says Britz-McKibbin. “Moreover, these compounds can be analyzed by mass spectrometry at incremental costs since it is already used for testing many other genetic diseases at newborn screening facilities around the world”
“Ontario started screening for Cystic Fibrosis in April 2007, and since that time over 400 children have already benefited from early recognition and early treatment. But for every one of these children, about 10 have had a false-positive result. We want to get this number down and are very hopeful that the new biomarkers discovered by this research project will help us do exactly that,” says Pranesh Chakraborty, medical director of NSO at CHEO.
In Canada, life expectancy rates have risen dramatically with the median age of survival now over 50 years, due to better treatments to improve lung function, better nutrition, lung transplants. The advent of universal newborn screening programs for CF will likely further improve the quality of life of affected patients.
“We know that early detection can have significant benefits for people living with cystic fibrosis,” said Dr. John Wallenburg, chief scientific officer at Cystic Fibrosis Canada. “The current screening methodologies capture a broad swathe of families that then need further testing to narrow down those that are true positives. The anxiety and distress that such further testing can needlessly cause families was a major concern that slowed the adoption of newborn screening in some jurisdictions. Dr. Britz-McKibbin’s data provide insights for more specific newborn screening, as well as early manifestations of the disease.”
The Latest on: Cystic fibrosis
via Google News
The Latest on: Cystic fibrosis
- Savannah Great Strides walk raising awareness to cystic fibrosison September 24, 2022 at 3:01 pm
The Savannah Great Strides walk was held Saturday at Tom Triplett Community Park. It’s a fundraising event for people living with cystic fibrosis.
- Cystic Fibrosis Foundation charges ahead with mission to find a cureon September 23, 2022 at 9:01 am
The Texas Gulf Coast Chapter of the Cystic Fibrosis Foundation was one of the first nonprofit organizations in town to transition to virtual operations in the early days of the pandemic, executive ...
- New cystic fibrosis treatment changing liveson September 23, 2022 at 8:27 am
PARIS: David Fiant says his cystic fibrosis and the arduous therapy it required was so bad he could no longer tell if I was living to heal myself or healing myself to live.While waiting for a ...
- Girl with cystic fibrosis sees symptoms ‘practically vanish’ after taking miracle NHS drugon September 23, 2022 at 7:15 am
Harriet Corr, seven, is regaining her strength after enduring years of coughing fits and a weakened immune system ...
- 'Tremendous hope': New cystic fibrosis treatment changing liveson September 23, 2022 at 6:06 am
David Fiant says his cystic fibrosis and the arduous therapy it required was so bad he "could no longer tell if I was living to heal myself or healing myself to live".
- Little girl with cystic fibrosis has virtually no symptoms after prescribed with miracle drugon September 22, 2022 at 7:52 pm
Little Harriet Corr, seven, is fighting fit again after enduring years of coughing fits, and a weakened immune system - linked to her condition.With her health declining, her mum, Emma Corr, 42, ...
- Cystic Fibrosis Market is Exhibit a CAGR of 17.85% By Product Type, Application, Key Players and Forecast to 2027 | Report [125 Pages]on September 21, 2022 at 9:10 pm
Report Pages No 125] In 2022, What is “Cystic Fibrosis Market” Insights? "Cystic Fibrosis market size was valued at ...
- Nine-year-old suffering with cystic fibrosis needs your helpon September 20, 2022 at 9:03 pm
R5 million is how much it costs for lifesaving medicine per year. But R55 000 buys my daughter one year’s worth of the generic medication that will keep her alive.”.
- Everything You Need To Know About Atypical Cystic Fibrosison September 18, 2022 at 7:56 am
So far, there is limited research on atypical cystic fibrosis. Luckily, what we do know reads as better news for those diagnosed with the disease.
- Children with cystic fibrosis protest with their parents outside Dáil over lack of life-changing drug Kaftrioon September 14, 2022 at 6:30 pm
An independent arbitrator has been called for to break the impasse between the HSE and the makers of the cystic fibrosis medicine Kaftrio after 35 children – aged six to 11 – were left without the ...
via Bing News